Patents by Inventor Cagla Eroglu

Cagla Eroglu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of Synaptogenesis
    Publication number: 20150133387
    Abstract: Soluble proteins, e.g. Hevin, can trigger synapse formation; and other soluble proteins, e.g. SPARC antagonize this activity. Such proteins are synthesized in vitro and in vivo by astrocytes. Methods are provided for protecting or treating an individual suffering from adverse effects of deficits in synaptogenesis, or from undesirably active synaptogenesis.
    Type: Application
    Filed: September 15, 2014
    Publication date: May 14, 2015
    Inventors: Benjamin A. Barres, Cagla Eroglu
  • Modulation of synaptogenesis
    Patent number: 8895507
    Abstract: Soluble proteins, e.g. Hevin, can trigger synapse formation; and other soluble proteins, e.g. SPARC antagonize this activity. Such proteins are synthesized in vitro and in vivo by astrocytes. Methods are provided for protecting or treating an individual suffering from adverse effects of deficits in synaptogenesis, or from undesirably active synaptogenesis.
    Type: Grant
    Filed: April 16, 2008
    Date of Patent: November 25, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Ben A. Barres, Cagla Eroglu
  • Treatment of neuropathic pain using anti-thrombospondin antibodies
    Patent number: 8491897
    Abstract: The present invention describes methods and compositions for modulating synaptogenesis and axon and/or dendritic growth. The methods include the use of agents that modulate a thrombospondin and/or an ?2? subunit of a calcium channel.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: July 23, 2013
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Cagla Eroglu, Ben A. Barres
  • MODULATION OF SYNAPTOGENESIS
    Publication number: 20110104181
    Abstract: The present invention describes methods and compositions for modulating synaptogenesis and axon and/or dendritic growth. The methods include the use of agents that modulate a thrombospondin and/or an ?2? subunit of a calcium channel.
    Type: Application
    Filed: October 15, 2010
    Publication date: May 5, 2011
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Cagla EROGLU, Ben A. BARRES
  • MODULATION OF SYNAPTOGENESIS
    Publication number: 20090053232
    Abstract: The present invention describes methods and compositions for modulating synaptogenesis and axon and/or dendritic growth. The methods include the use of agents that modulate a thrombospondin and/or an ?2? subunit of a calcium channel.
    Type: Application
    Filed: August 14, 2008
    Publication date: February 26, 2009
    Inventors: Cagla EROGLU, Ben A. BARRES
  • Modulation of synaptogenesis
    Publication number: 20090029909
    Abstract: Soluble proteins, e.g. Hevin, can trigger synapse formation; and other soluble proteins, e.g. SPARC antagonize this activity. Such proteins are synthesized in vitro and in vivo by astrocytes. Methods are provided for protecting or treating an individual suffering from adverse effects of deficits in synaptogenesis, or from undesirably active synaptogenesis.
    Type: Application
    Filed: April 16, 2008
    Publication date: January 29, 2009
    Inventors: Ben A. Barres, Cagla Eroglu